Invitation to the 2026 CASL Single Topic Conference on Steatotic Liver Disease (CASL STC 2026)
Dear Colleagues and Friends,
We are delighted to invite you to the 2026 CASL Single Topic Conference on Steatotic Liver Disease (CASL STC), which will take place on September 18 and 19, 2026, in Montréal, Quebec, Canada.
The CASL STC will provide an interactive, platform for knowledge exchange within the steatotic liver disease community. The event will feature a range of topics From Evidence to Action, including:
- Global Policy Levers for Liver Health
- Prevention and root causes of steatotic liver disease
- Early detection and care pathways
- Equitable treatment and access to care
- Multidisciplinary focus on clinical management
- Therapeutic innovation and future treatment models
- SLD Across Sex, Gender, and Life Course
Our esteemed local, national and international speakers will share the latest research findings, clinical practices, and technological advancements, aiming to inspire future research and innovation in these fields.
The CASL STC will offer valuable opportunities for professional growth, knowledge exchange, and collaboration within the liver disease community.
The conference is conveniently located in the accessible city of Montréal in Quebec, Canada. We encourage you to explore Montréal’s attractions, vibrant culture, and delicious cuisine during your stay.
We look forward to welcoming you to the CASL STC, which promises to be both engaging and inspiring.
Warm regards,

Sahar Saeed, MSc, PhD
CASL STC 2026 Co-Chair
Assistant Professor, Department of Public Health Sciences,
Queen’s University

Jennifer Flemming, MD MAS
CASL STC 2026 Co-Chair
Professor, Medicine and Public Health Sciences, Queen’s University